MERIDIAN BIOSCIENCE INC's ticker is VIVO and the CUSIP is 589584101. A total of 180 filers reported holding MERIDIAN BIOSCIENCE INC in Q3 2021. The put-call ratio across all filers is 1.08 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $1,141 | -99.9% | 34,363 | 0.0% | 0.02% | -3.8% |
| Q3 2022 | $1,083,000 | +3.6% | 34,363 | 0.0% | 0.03% | +8.3% |
| Q2 2022 | $1,045,000 | +17.2% | 34,363 | 0.0% | 0.02% | +33.3% |
| Q1 2022 | $892,000 | +3.0% | 34,363 | -19.1% | 0.02% | +28.6% |
| Q4 2021 | $866,000 | +6.0% | 42,463 | 0.0% | 0.01% | -6.7% |
| Q3 2021 | $817,000 | -13.3% | 42,463 | 0.0% | 0.02% | -11.8% |
| Q2 2021 | $942,000 | -11.3% | 42,463 | +5.0% | 0.02% | -5.6% |
| Q1 2021 | $1,062,000 | +41.8% | 40,453 | +0.9% | 0.02% | +28.6% |
| Q4 2020 | $749,000 | +10.0% | 40,100 | 0.0% | 0.01% | -6.7% |
| Q3 2020 | $681,000 | -27.1% | 40,100 | 0.0% | 0.02% | -31.8% |
| Q2 2020 | $934,000 | +177.2% | 40,100 | 0.0% | 0.02% | +144.4% |
| Q1 2020 | $337,000 | +80.2% | 40,100 | +109.9% | 0.01% | +125.0% |
| Q4 2019 | $187,000 | +3.3% | 19,100 | 0.0% | 0.00% | 0.0% |
| Q3 2019 | $181,000 | – | 19,100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SYQUANT CAPITAL SAS | 134,804 | $4,477 | 11.01% |
| Vazirani Asset Management LLC | 115,774 | $3,845 | 6.51% |
| FIFTH LANE CAPITAL, LP | 185,914 | $6,174,204 | 5.56% |
| NEXPOINT ASSET MANAGEMENT, L.P. | 1,939,075 | $64,396,681 | 5.01% |
| Crystalline Management Inc. | 244,453 | $8,118,284 | 4.08% |
| FNY Investment Advisers, LLC | 51,000 | $1,693 | 2.36% |
| HAVENS ADVISORS LLC | 26,800 | $890,028 | 2.26% |
| Euclidean Technologies Management, LLC | 62,995 | $2,092,064 | 1.99% |
| Sand Grove Capital Management LLP | 537,060 | $17,836 | 1.70% |
| Crabel Capital Management, LLC | 120,337 | $3,996 | 1.45% |